Retreatment with upadacitinib in atopic dermatitis: experience in clinical practice

被引:2
|
作者
Martinez-Fernandez, S. [1 ]
Suh-Oh, H. J.
Batalla, A.
Couselo-Rodriguez, C.
Espasandin-Arias, M.
Florez, A.
机构
[1] Univ Hosp Pontevedra, Dept Dermatol, Pontevedra, Spain
关键词
D O I
10.1080/09546634.2023.2242543
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
引用
收藏
页数:3
相关论文
共 50 条
  • [1] Treatment of atopic dermatitis with upadacitinib: adcare single center experience
    Fomina, Daria S.
    Mukhina, Olga A.
    Mikhailova, Valeria I.
    Lebedkina, Marina S.
    Sedova, Elizaveta L.
    Bobrikova, Elena N.
    Elisyutina, Olga G.
    Fedenko, Elena S.
    Nurpeisov, Tair T.
    Karaulov, Alexander V.
    Lysenko, Mar'yana A.
    Ensina, Luis Felipe C.
    FRONTIERS IN MEDICINE, 2024, 11
  • [3] Upadacitinib for the treatment of moderate-to-severe atopic dermatitis in real-world clinical practice
    Tran, Vanessa
    Ross, Gayle
    AUSTRALASIAN JOURNAL OF DERMATOLOGY, 2023, 64 : 11 - 11
  • [4] Successful response of upadacitinib in different clinical phenotypes of atopic dermatitis
    Gori, Niccolo
    Quaglino, Pietro
    Chiricozzi, Andrea
    Marzano, Angelo Valerio
    Argenziano, Giuseppe
    Girolomoni, Giampiero
    Bianchi, Luca
    Fargnoli, Maria Concetta
    Ortoncelli, Michela
    Di Nardo, Lucia
    Ferrucci, Silvia Mariel
    Caccavale, Stefano
    Maurelli, Martina
    Galluzzo, Marco
    Esposito, Maria
    Peris, Ketty
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2025,
  • [5] Treatment of Severe Atopic Dermatitis With Upadacitinib in Clinical Practice: Short-Term Efficacy and Safety Results
    Pereyra-Rodriguez, J. J.
    Herranz, P.
    Figueras-Nart, I
    Perez, B.
    Elosua, M.
    Munera-Campos, M.
    Melgosa-Ramos, J.
    Zaragoza, V
    Silvestre, J. F.
    Campos-Dominguez, M.
    Guilabert, A.
    Miquel, J.
    Alcantara-Luna, S.
    de la Cueva, P.
    Serra-Baldrich, E.
    Armario-Hita, J. C.
    Rodriguez, Jose Juan Pereyra
    JOURNAL OF INVESTIGATIONAL ALLERGOLOGY AND CLINICAL IMMUNOLOGY, 2023, 33 (03) : 211 - 213
  • [6] Effectiveness and safety of upadacitinib retreatment after withdrawal in moderate-to-severe atopic dermatitis: a retrospective study
    Hagino, Teppei
    Saeki, Hidehisa
    Fujimoto, Eita
    Kanda, Naoko
    CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2024,
  • [7] Upadacitinib for moderate to severe atopic dermatitis
    Navarro-Trivino, Francisco
    Alcantara-Luna, Sara
    Dominguez-Cruz, Javier
    Galan-Gutierrez, Manuel
    Ruiz-Villaverde, Ricardo
    Pereyra-Rodriguez, Jose-Juan
    Armario-Hita, Jose-Carlos
    IMMUNOTHERAPY, 2023, 15 (11) : 799 - 808
  • [8] Impact of Upadacitinib on Atopic Keratoconjunctivitis Exacerbated by Dupilumab Treatment in Atopic Dermatitis Patients: A Prospective Dermatological and Ophthalmological Clinical Evaluation in Common Clinical Practice
    Paganini, Claudia
    Spelta, Sara
    Tofani, Lorenzo
    Talamonti, Marina
    Bianchi, Luca
    Coassin, Marco
    Di Zazzo, Antonio
    Galluzzo, Marco
    JOURNAL OF CLINICAL MEDICINE, 2024, 13 (13)
  • [9] A real-world Australian experience of upadacitinib for the treatment of severe atopic dermatitis
    Tran, Vanessa
    Ross, Gayle
    AUSTRALASIAN JOURNAL OF DERMATOLOGY, 2023, 64 (04) : e352 - e356
  • [10] The Usefulness of Atopic Dermatitis Control Tool in Upadacitinib Treatment for Patients with Atopic Dermatitis
    Hagino, Teppei
    Saeki, Hidehisa
    Fujimoto, Eita
    Kanda, Naoko
    DERMATOLOGIC THERAPY, 2024, 2024